Showcases Stock ranks Forex

Pfizer Inc (PFE)
40.39  0.21 (0.52%) 03-24 16:03
Open: 40.09 Pre. Close: 40.18
High: 40.455 Low: 39.8748
Volume: 17,132,360 Market Cap: 227,977(M)
Stock Technical Analysis
Target: Six months: 48.81
One year: 50.66
Support: Support1: 39.23
Support2: 32.64
Resistance: Resistance1: 41.79
Resistance2: 43.37
Pivot: 40.20
Moving Averages: MA(5): 40.41
MA(20): 40.31
MA(100): 46.18
MA(250): 47.89
MACD: MACD(12,26): -0.73
Signal(12,26,9): -0.94
%K %D: %K(14,3): 47.45
%D(3): 53.86
RSI: RSI(14): 41.65
52-Week: High: 56.32
Low: 39.23
Change(%): -23.0
Average Vol(K): 3-Month: 22837
10-Days: 24761
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 40.498 - 40.653 40.653 - 40.832
Low: 39.442 - 39.611 39.611 - 39.805
Close: 40.075 - 40.347 40.347 - 40.659
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.

[ PFE ] has closed below upper band by 39.2%. Bollinger Bands are 59.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
Company profile
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Stock chart
Stock News
Sat, 25 Mar 2023
Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of ... - MarketBeat

Fri, 24 Mar 2023
Analyst Rating: Will Pfizer Inc. (PFE) Stock Lead the Market? - InvestorsObserver

Fri, 24 Mar 2023
Investment Partners LTD. Sells 36737 Shares of Pfizer Inc. (NYSE ... - MarketBeat

Thu, 23 Mar 2023
Pfizer Inc. (PFE) Stock: A Value Analysis - The News Heater

Mon, 20 Mar 2023
Pfizer Inc. (NYSE:PFE) Stock Position Trimmed by North Star Asset ... - MarketBeat

Mon, 20 Mar 2023
Insiders at Pfizer Inc. (NYSE:PFE) sold US$7.6m worth of stock, possibly indicating weakness in the future - Simply Wall St

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. (M) 5640.00
Shares Float (M) 5610.00
% Held by Insiders 0.03
% Held by Institutions 70.77
Shares Short (K) 38490
Shares Short Prior Month (K) 39170
Stock Financials
EPS 5.450
Book Value (p.s.) 17.030
Profit Margin 31.27
Operating Margin 38.87
Return on Assets (ttm) 12.9
Return on Equity (ttm) 36.2
Qtrly Rev. Growth 1.9
Gross Profit (p.s.) 11.743
Sales Per Share 17.789
EBITDA (p.s.) 7.805
Qtrly Earnings Growth 47.10
Operating Cash Flow (M) 29270.00
Levered Free Cash Flow (M) 24960.00
Stock Valuation
PE Ratio 7.41
PEG Ratio -2.19
Price to Book value 2.37
Price to Sales 2.27
Price to Cash Flow 7.78
Stock Dividends
Dividend 0.410
Dividend Yield 0.01
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android